Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doxycycline in lymphangioleiomyomatosis (randomised double blind placebo-controlled)
2007-003745-32Phase 4Completed
- Sponsor
- University of Nottingham
- Start
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in lymphangioleiomyomatosis (LAM) comparing Doxycycline with Placebo (2 arms). Primary endpoint: Mean rate of change of FEV1/year over 24 months. Started Nov 2010; status: completed.
02
Drugs
doxycycline
03
Conditions
lymphangioleiomyomatosis (LAM)
Beyond the preview
Go deeper on 2007-003745-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-003745-32.